University of Tennessee Medical Center Participates in Plasma Delivery Study - News - @

University of Tennessee Medical Center Participates in Plasma Delivery Study

Center and LifeStar helicopters part of stage 3 clinical trial


KRISTI L. NELSON, Knoxville News-Sentinel | | Thursday, April 10, 2014

In matters of life and death, minutes can mean a different outcome.

A clinical trial at University of Tennessee Medical Center seeks to find out how much of a difference it might make if trauma patients being airlifted with uncontrolled bleeding get blood plasma treatments before they even get to the hospital.

The medical center and its LifeStar helicopters are one of six sites participating in the Pre-hospital Air Medical Plasma Trial (PAMPr), a stage 3 clinical trial backed by the U.S. Department of Defense and headed up by the University of Pittsburgh.

The military has found giving plasma, which can clot, more quickly to soldiers injured in combat zones resulted in better survival rates, said Dr. Brian Daley, UTMC trauma medical director and principal study investigator. This new trial will see if a civilian population of varying ages and health conditions fares as well as soldiers, who are generally younger and healthier, he said.

It’s the timing, rather than the treatment itself, that’s being tested. Many trauma patients already get plasma once in the hospital’s emergency department, in an attempt to stop hemorrhaging and significant blood loss, which can lead to low blood pressure, multiple organ failure and other issues that greatly increase the risk of death or disability.

The trial will test whether there’s an advantage to getting those patients the plasma at the earliest possible moment: during transport via LifeStar to UTMC, which can be anywhere from 20 minutes to two hours, depending on the patient’s location, Daley said.

“We already know there’s benefit, but we’re trying to adjust the timing and look for adverse reactions,” he said. “We’re hopeful, but as scientists, we wait for the evidence.”

Initially, two units of AB plasma — the type given in emergencies before the patient’s blood type is known — will be placed on the LifeStar copter based in Morristown. Once a routine is established, the other three LifeStar copters will likely carry plasma as well, said LifeStar medical director Dr. Chris Brooks. It will be given in-flight to qualifying trauma patients every other month, with the non-plasma months serving to form a “control group.”

The hope, is that the trial will show great benefit to the patients, which will then make in-flight plasma treatments a standard of care, Brooks said.

That could change the way Medic Regional Blood Center, the sole supplier for UTMC and other area hospitals, collects plasma, said Medic chief operating officer Eva Quinley. Blood type AB plasma is “universal,” used in emergencies when a patient’s blood type is unknown, just as Type O red blood cells are.

But less than 4 percent of the population has blood type AB, Quinley said, and a new protocol suggests blood centers collect AB plasma only from men or from women who have never been pregnant, because women who have carried children sometimes have an antibody that render the plasma unusable in emergency situations, and testing for it on a large scale is cost-prohibitive.

Quinley said Medic is able to supply UTMC’s AB plasma needs for this trial, but if it becomes a standard of care, Medic may change its own protocol. Currently it gets plasma by taking whole-blood donation and separating the red blood cells from the plasma, both for use.

However, there’s much less demand for AB red blood cells than for AB plasma, so if the demand for AB plasma locally increases, Medic might invest in a machine that takes only plasma and returns the red blood cells to the body, Quinley said.

Daley said UTMC is “very good about making sure blood products never get wasted.” For him, the most time-consuming part of setting up the study has been obtaining “community consent” — the formal board-reviewed process that means that by becoming a LifeStar trauma patient, people are considered to have “consented” to participate, unless they “opt out” by wearing a bracelet (or carrying a card, as Jehovah’s Witnesses and others with religious prohibitions do). Even though the risk is “minimal” — patients would get the plasma anyway, just later — it took about 16 months to get consent, he said. Community members can “opt out” by calling Meghan Buck at 855-730-8140 or visiting

Otherwise, patients ages 18 to 90 are eligible, with some exceptions, such as those with penetrating head wounds, or drowning or hanging victims. Brooks said LifeStar typically transports up to 1,250 trauma patients a year.

“There’s some good evidence this will significantly improve outcomes for these patients,” he said. “Every time we have a war, we have an advance in trauma care.”

Mobile Category: 

Copyright © 2013 LexisNexis, a division of Reed Elsevier Inc. All rights reserved. Terms and Conditions | Privacy Policy

Connect: Have a thought or feedback about this? Add your comment now
Related Topics: News, study, clinical trial

What's Your Take? Comment Now ...

Buyer's Guide Featured Companies

Featured Careers & Jobs in EMS

Get JEMS in Your Inbox


Fire EMS Blogs

Blogger Browser

Today's Featured Posts


EMS Airway Clinic

Improving Survival from Cardiac Arrest Using ACD-CPR + ITD

Using active compression-decompression CPR with an ITD has been shown to improve 1-year survival from cardiac arrest by 33%.
More >

Multimedia Thumb

Three Injured in Philadelphia Collapse

Parapet wall falls through roof of store.
Watch It >

Multimedia Thumb

California Firefighters save Man on Flight

Patient was conscious and talking when United flight landed.
Watch It >

Multimedia Thumb

Over Half of Seattle Fire Stations Test Positive for MRSA

Surprisingly high results come from test kits based on earlier study.
Watch It >

Multimedia Thumb

Hands On February 2015

Here’s a look at this month’s product hands on.
More >

Multimedia Thumb

Nightwatch Series Premiere Party

JEMS Editor-in-Chief A.J. Heightman attends the series premiere of A&E's new reality show, "Nightwatch."
More >

Multimedia Thumb

Ottawa Chemical Investigation

Chemicals and suspicious package are probed at two locations
More >

Multimedia Thumb

LMA MAD Nasal™

Needle-free intranasal drug delivery.
Watch It >

Multimedia Thumb

VividTrac offered by Vivid Medical - EMS Today 2013

VividTrac, affordable high performance video intubation device.
Watch It >

Multimedia Thumb

Field Bridge Xpress ePCR on iPad, Android, Kindle Fire

Sneak peek of customizable run forms & more.
Watch It >

Multimedia Thumb

Braun Ambulances' EZ Door Forward

Helps to create a safer ambulance module.
Watch It >

More Product Videos >